Biphasic response to nitric oxide of spinal trigeminal neurons with meningeal input in rat-possible implications for the pathophysiology of headaches

Journal of Neurophysiology

Volumn 92, Issue 3, 2004, Pages 1320-1328

  Koulchitsky, Stansilav ^a   Fischer, Michael J M ^a   De Col, Roberto ^a   Schlechtweg, Philipp M ^a   Messlinger, Karl ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PHENTOLAMINE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BRAIN CIRCULATION; CONTROLLED STUDY; DURA MATER; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; GENE EXPRESSION; HEADACHE; LATENT PERIOD; MALE; MEDULLA OBLONGATA; MIGRAINE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RECEPTIVE FIELD; TRIGEMINAL NERVE;

ACTION POTENTIALS; ANIMALS; ELECTRIC STIMULATION; HEADACHE; MALE; MENINGES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE; RATS; RATS, WISTAR; TRIGEMINAL NERVE;

EID: 4143123502     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.01210.2003     Document Type: Article

References (80)

1. Arbab MAR, Delgado T, Wiklund L, and Svendgaard NA. Brain stem terminations of the trigeminal and upper spinal innervation of the cerebrovascular system. J Cereb Blood Flow Metab 8: 54-63, 1988.
2. Ashina M, Bendtsen L, Jensen R, Lassen LH, Sakai F, and Olesen J. Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. Brain 122: 1629-1635, 1999.
3. Bank J. Migraine with aura after administration of sublingual nitroglycerin tablets. Headache 41: 84-87, 2001.
4. Brunetti L. Nitric oxide: a gas as a modulator of neuroendocrine secretions. Clin Ter 144: 147-53, 1994.
5. Bullitt E. Expression of C-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J Comp Neurol 296: 517-530, 1990.
6. Burstein R, Yamamura H, Malick A, and Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79: 964-982, 1998.
7. Chen JX, Berry LC, Tanner M, Chang M, Myers RP, and Meyrick B. Nitric oxide donors regulate nitric oxide synthase in bovine pulmonary artery endothelium. J Cell Physiol 186: 116-123, 2001.
8. Dalsgaard-Nielsen T. Migraine diagnostics with special reference to pharmacological tests. Int Arch Allerg 7: 312-322, 1955.
9. D'Amico D, Ferraris A, Leone M, Catania A, Carlin A, Grazzi L, and Bussone G. Increased plasma nitrites in migraine and cluster headache patients in interictal period: basal hyperactivity of L-arginine-NO pathway? Cephalalgia 22: 33-36, 2002.
10. Davis KD, Meyer RA, and Campbell JN. Chemosensitivity and sensitization of nociceptive afferents that innervate the hairy skin of monkey. J Neurophysiol 69: 1071-1081, 1993.
11. De Col R, Koulchitsky SV, and Messlinger KB. Nitric oxide synthase inhibition lowers activity of neurons with meningeal input in the rat spinal trigeminal nucleus. Neuroreport 14: 229-232, 2003.
12. Dohrn CS and Beitz AJ. NMDA receptor mRNA expression in NOS-containing neurons in the spinal trigeminal nucleus of the rat. Neurosci Lett 175: 28-32, 1994.
13. Dragunow M and Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29: 261-265, 1989.
14. Ekbom K. Nitroglycerin as a provocative agent in cluster headache. Arch Neurol 19: 487-493, 1968.
15. Feindel W, Penfield W, and McNaughton F. The tentorial nerves and localisation of intracranial pain in man. Neurology 10: 555-563, 1960.
16. Forster C and Handwerker HO. Automatic classification and analysis of microneurographic spike data using a PC/AT. J Neurosci Methods 31: 109-118, 1990.
17. Gallai V, Alberti A, Gallai B, Coppola F, Floridi A, and Sarchielli P. Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid. Cephalalgia 23: 166-174, 2003.
18. Garthwaite JG and Boulton CL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57: 683-706, 1995.
19. Graham JR and Wolff HG. Mechanism of migraine headache and action of tartrate. Arch Neurol Psychiatry 38: 737-763, 1938.
20. Handwerker HO and Reeh PW. Pain and inflammation. In: Proceedings of the VIth World Congress on Pain, edited by Bond MR, Charlton JE, and Woolf CJ. Amsterdam: Elsevier, 1991, p. 59-70.
21. Holzer P, Jocic M, and Peskar BA. Mediation by prostaglandins of the nitric oxide-induced neurogenic vasodilatation in rat skin. Br J Pharmacol 116: 2365-2370, 1995.
22. Honore P, Chapman V, Buritova J, and Besson J-M. Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor. Br J Pharmacol 114: 77-84, 1995.
23. Ikeda S, Frank PA, Schweiss JF, and Homan SM. In vitro cyanide release from sodium nitroprusside in various intravenous solutions. Anesth Analg 4: 360-362, 1988.
24. Iversen HK, Olesen J, and Tfelt-Hansen P. Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 38: 17-24, 1989.
25. Iwamoto ET and Marion L. Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats. J Pharmacol Exp Ther 269: 699-708, 1994.
26. Jansen I, Uddman R, Ekman R, Olesen J, Ottosson A, and Edvinsson L. Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene-related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries. Peptides 13: 527-536, 1992.
27. Jones MG, Lever I, Bingham S, Read S, McMahon SB, and Parsons A. Nitric oxide potentiates response of trigeminal neurones to dural or facial stimulation in the rat. Cephalalgia 21: 643-655, 2001.
28. Kaube H, Keay KA, Hoskin KL, Bandler R, and Goadsby PJ. Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res 629: 95-102, 1993.
29. Kiechle FL and Malinski T. Nitric oxide biochemistry, pathophysiology and detection. Am J Clin Pathol 100: 567-573, 1993.
30. Lassen LH, Ashina M, Christiansen I, Ulrich V, and Olesen J. Nitric oxide synthase inhibition in migraine. Lancet 349: 401-402, 1997.
31. Lassen LH, Ashina M, Christiansen I, Ulrich V, Grover R, Donaldson J, and Olesen J. Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia 18: 27-32, 1998.
32. Lee JH, Wilcox GL, and Beitz AJ. Nitric oxide mediates Fos expression of c-fos in the spinal cord induced by noxious stimulation. Neuroreport 3: 841-844, 1992.
33. Leger L, Gay N, Burlet S, Charnay Y, and Cespuglio R. Localization of nitric oxide-synthesizing neurons sending projections to the dorsal raphe nucleus of the rat. Neurosci Lett 257: 147-150, 1998.
34. Leong S, Liu H, and Yeo J. Nitric oxide synthase and glutamate receptor immunoreactivity in the rat spinal trigeminal neurons expressing Fos protein after formalin injection. Brain Res 855: 107-115, 2000.
35. Malmberg AB and Yaksh TL. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 54: 291-300, 1993.
36. Mayberg R, Zervas NT, and Moskowitz MA. Trigeminal projections to supratentorial pial and dural blood vessels. J Comp Neurol 223: 45-56, 1984.
37. Mayer B. Regulation of nitric oxide synthase and soluble guanydil cyclase. Cell Biochem Funct 12: 167-177, 1994.
38. Meller ST and Gebhart GF. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52: 127-136, 1993.
39. Messlinger K, Suzuki A, Pawlak M, Zehnter A, and Schmidt RF. Involvement of nitric oxide in the modulation of dural arterial blood flow in the rat. Br J Pharmacol 129: 1397-1404, 2000.
40. Mizumura K, Sato J, and Kumazawa T. Effects of prostaglandins and other putative chemical intermediators on the activity of canine testicular polymodal receptors studied in vitro. Pfluegers 408: 565-572, 1987.
41. Moncada S, Palmer RMJ, and Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142, 1991.
42. Moore PK, Babbedge RC, Wallace P, Gaffen ZA, and Hart SL. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol 108: 296-297, 1993.
43. Morgan JI and Curran T. Stimulus-transcription coupling in the nervous system. Involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 14: 421-451, 1991.
44. Moskowitz MA and Macfarlane R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc Brain Metab Rev 5: 159-177, 1993.
45. Olesen J, Iversen HK, and Thomsen LL. Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport 4: 1027-1030, 1993.
46. Olesen J and Jansen-Olesen I. Nitric oxide mechanisms in migraine. Pathol Biol (Paris) 48: 648-657, 2000.
47. Olesen J, Thomsen LL, and Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 15: 149-153, 1994.
48. Olesen J, Thomsen LL, Lassen LH, and Olesen IJ. The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 15: 94-100, 1995.
49. Pardutz A, Krizbai I, Multon S, Vecsei L, and Schoenen J. Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis. Neuroreport 11: 3071-3075, 2000.
50. Peters GA. Migraine: diagnosis and treatment with emphasis on the migraine-tension headache, provocative tests and use of rectal suppositories. Proc Staff Meet Mayo Clin 28: 673-686, 1953.
51. Pogun S and Kuhar MJ. Regulation of neurotransmitter reuptake by nitric oxide. Ann NY Acad Sci 738: 305-315, 1994.
52. Ray BS and Wolff HG. Experimental studies on headache: pain-sensitive structures of the head and their significance in headache. Arch Surg 41: 813-856, 1940.
53. Reuter U, Bolay H, Jansen-Olesen I, Chiarugi A, Sanchez del Rio M, Letourneau R, Theoharides TC, Waeber C, and Moskowitz MA. Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 124: 2490-2502, 2001.
54. Riedel W. Role of nitric oxide in the control of the hypothalamic- pituitary-adrenocortical axis. Z Rheumatol 59, Suppl 2: 36-42, 2000.
55. Saito K, Greenberg S, and Moskowitz MA. Trigeminal origin of beta-preprotachykinin products in feline pial blood vessels. Neurosci Lett 76: 69-73, 1987.
56. Sarchielli P, Alberti A, Codini M, Floridi A, and Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 20: 907-918, 2000.
57. Schepelmann K, Ebersberger A, Pawlak M, Oppmann M, and Messlinger K. Response properties of trigeminal brain stem neurons with input from dura mater encephali in the rat. Neuroscience 90: 543-554, 1999.
58. Shimomura T, Murakami F, Kotani K, Ikawa S, and Kono S. Platelet nitric oxide metabolites in migraine. Cephalalgia 19: 218-222, 1999.
59. Steen KH, Reeh PW, Anton F, and Handwerker HO. Protons selectively induce lasting excitation and sensitization to mechanical stimulation of nociceptors in rat skin, in vitro. J Neurosci 12: 86-95, 1992.
60. Steen KH, Steen AE, and Reeh PW. A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin in vitro. J Neurosci 15: 3982-3989, 1995.
61. Stirparo G, Zicari A, Favilla M, Lipari M, and Martelletti P. Linked activation of nitric oxide synthase and cyclooxygenase in peripheral monocytes of asymptomatic migraine without aura patients. Cephalalgia 20: 100-106, 2000.
62. Strassman AM, Mason P, Moskowitz MA, and Maciewicz R. Response of brain stem trigeminal neurones to electrical stimulation of the dura. Brain Res 379: 242-250, 1986.
63. Strassman AM and Vos BP. Somatotopic and laminar organisation of fos-like immunoreactivity in the medullary and upper cervical dorsal horn induced by noxious facial stimulation in the rat. J Comp Neurol 331: 495-516, 1993.
64. Strassman AM, Raymond SA, and Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384: 560-564, 1996.
65. Strecker T, Dux M, and Messlinger K. Increase in meningeal blood flow by nitric oxide - interaction with calcitonin gene-related peptide receptor and prostaglandin synthesis inhibition. Cephalalgia 22: 233-241, 2002.
66. Tassorelli C and Joseph SA. Systemic nitroglycerin induces fos immunoreactivity in brain stem and forebrain structures of the rat. Brain Res 682: 67-78, 1995a.
67. Tassorelli C and Joseph SA. NADPH-diaphorase activity and fos expression in brain nuclei following nitroglycerin administration. Brain Res 695: 37-44, 1995b.
68. Tassorelli C, Joseph SA, and Nappi G. Neurochemical mechanisms of nitroglycerin-induced neuronal activation in rat brain: a pharmacological investigation. Neuropharmacology 36: 1417-1424, 1997.
69. Tassorelli C, Joseph SA, Buzzi MG, and Nappi G. The effects on the central nervous system of nitroglycerin-putative mechanisms and mediators. Prog Neurobiol 57: 607-624, 1999.
70. Thomsen LL, Kruuse C, Iversen HK, and Olesen J. A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol 1: 73-80, 1994.
71. Thomsen LL and Olesen J. Nitric oxide theory of migraine. Clin Neurosci 5: 28-33, 1998.
72. Uddman R, Edvinsson L, Ekman R, Kingman T, and McCulloch J. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett 62: 131-136, 1985.
73. Uddman R, Hara H, and Edvinsson L. Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistry. J Auton Nerv Syst 26: 69-75, 1989.
74. van der Kuy PH, Merkus FW, Lohman JJ, ter Berg JW, and Hooymans PM. Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study. Cephalalgia 22: 513-519, 2002.
75. Vetter G, Geisslinger G, and Tegeder I. Release of glutamate, nitric oxide and prostaglandin E2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation. Pain 92: 213-218, 2001.
76. Wang X and Robinson PJ. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J Neurochem 68: 443-456, 1997.
77. Wiertelak EP, Furness LE, Watkins LR, and Maier SF. Illness-induced hyperalgesia is mediated by a spinal NMDA-nitric oxide cascade. Brain Res 664: 9-16, 1994.
78. Wolff HG. Headache and Other Head Pain (2nd ed.). New York: Oxford University, 1963.
79. Yamamura H, Malick A, Chamberlin NL, and Burstein R. Cardiovascular and neuronal responses to head stimulation reflect central sensitization and cutaneous allodynia in a rat model of migraine. J Neurophysiol 81: 479-493, 1999.
80. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110, 1983.